Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The prevalence of vitamin D deficiency and insufficiency was higher in the experimental group (69.35%) than in the control group (36.64%), with a statistically significant difference (p < 0.05).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
All participants were aged ≥11 years and <18 years, a developmental period classified as adolescence by the World Health Organization.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy
Study design awaiting verification · Brain and Behavior · 2025
Original publication title
Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy
© 2025 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To investigate the correlation between serum 25‐hydroxyvitamin D3 (25‐(OH)D3) levels and anxiety disorders in adolescents, and to assess the potential impact of vitamin D status on pediatric anxiety disorders, thereby providing clinical evidence for diagnosis and treatment.
Source: ObjectiveAbstract: What methods does the paper describe?
This study included 124 adolescents with anxiety disorders who visited the pediatric outpatient department of Jingzhou First People's Hospital from January 2020 to December 2022 as the experimental group and 131 healthy adolescents who underwent physical examinations during the same period as the control group. Serum 25‐(OH)D3 levels were compared between the two groups. Simple linear regression analysis was conducted to evaluate the predictive capacity of 25‐(OH)D3 levels on anxiety scores in the experimental group. Additionally, 86 adolescents with anxiety disorders and 25‐(OH)D deficiency or insufficiency in the experimental group received vitamin D supplementation for 12 weeks, and changes in anxiety scores before and after supplementation were analyzed to assess the effect of 25‐(OH)D3 levels on anxiety disorders.
Source: MethodsAbstract: Results
The mean serum 25‐(OH)D3 level in the experimental group [(16.48 ± 6.53) ng/ml] was significantly lower than that in the control group [(22.95 ± 7.25) ng/ml], with a statistically significant difference (p < 0.05). The prevalence of vitamin D deficiency and insufficiency was higher in the experimental group (69.35%) than in the control group (36.64%), with a statistically significant difference (p < 0.05). Furthermore, in the experimental group, anxiety scores were negatively correlated with serum 25‐(OH)D3 levels, indicating that lower 25‐(OH)D3 levels were associated with higher anxiety scores.
After vitamin D supplementation, adolescents with anxiety disorders and 25‐(OH)D deficiency or insufficiency exhibited reduced anxiety scores.
Source: ResultsAbstract: Conclusion
Vitamin D deficiency may represent a potential risk factor for anxiety disorders in adolescents and demonstrate some predictive value for these conditions. Vitamin D supplementation could potentially alleviate anxiety symptoms in adolescents.
Source: ConclusionAuthors’ abstract
ABSTRACT
Objective
To investigate the correlation between serum 25‐hydroxyvitamin D3 (25‐(OH)D3) levels and anxiety disorders in adolescents, and to assess the potential impact of vitamin D status on pediatric anxiety disorders, thereby providing clinical evidence for diagnosis and treatment.
Methods
This study included 124 adolescents with anxiety disorders who visited the pediatric outpatient department of Jingzhou First People's Hospital from January 2020 to December 2022 as the experimental group and 131 healthy adolescents who underwent physical examinations during the same period as the control group. Serum 25‐(OH)D3 levels were compared between the two groups. Simple linear regression analysis was conducted to evaluate the predictive capacity of 25‐(OH)D3 levels on anxiety scores in the experimental group. Additionally, 86 adolescents with anxiety disorders and 25‐(OH)D deficiency or insufficiency in the experimental group received vitamin D supplementation for 12 weeks, and changes in anxiety scores before and after supplementation were analyzed to assess the effect of 25‐(OH)D3 levels on anxiety disorders.
Results
The mean serum 25‐(OH)D3 level in the experimental group [(16.48 ± 6.53) ng/ml] was significantly lower than that in the control group [(22.95 ± 7.25) ng/ml], with a statistically significant difference (p < 0.05). The prevalence of vitamin D deficiency and insufficiency was higher in the experimental group (69.35%) than in the control group (36.64%), with a statistically significant difference (p < 0.05). Furthermore, in the experimental group, anxiety scores were negatively correlated with serum 25‐(OH)D3 levels, indicating that lower 25‐(OH)D3 levels were associated with higher anxiety scores.
After vitamin D supplementation, adolescents with anxiety disorders and 25‐(OH)D deficiency or insufficiency exhibited reduced anxiety scores.
Conclusion
Vitamin D deficiency may represent a potential risk factor for anxiety disorders in adolescents and demonstrate some predictive value for these conditions. Vitamin D supplementation could potentially alleviate anxiety symptoms in adolescents.
Publication and source details
Original title: Serum 25‐Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case‐Control and Vitamin D Supplementation Substudy
Wan Linfang; Liu Yang
Brain and Behavior · 2025
© 2025 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Science and Technology Research Project of the Education Department of Hubei Province Grant No. B2023026Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:28:36.896651+00:00
DOI: 10.1002/brb3.71095 · PMC12665044